Park City Angels
Robert "Rob" Sinnott is a highly experienced professional in the fields of nutrition, dietary supplements, and biotechnology. Currently serving as a member of Park City Angels and a board member of the Council of Responsible Nutrition, Sinnott also holds the position of Chief Scientific Officer at USANA Health Sciences, where responsibilities include overseeing global research and product development. Prior roles include CEO and Chief Scientific Officer at Mannatech, Inc., where significant operational transformations were implemented, and co-founder and CEO of Larreacorp, Ltd., focusing on dietary supplement and cosmetic R&D. Sinnott’s academic credentials include a Ph.D. in Biotechnology from Arizona State University and multiple prestigious executive education programs from top business schools.
This person is not in the org chart
This person is not in any teams
Park City Angels
The Park City Angels are a group of 50+ accredited investors located in Park City, Utah. We look to invest in promising opportunities that can produce significant shareholder return. The active lifestyle of Park City has attracted many dynamic and successful business leaders that have deep experience in building world class businesses. We facilitate unique, high-caliber networking and development forums for angel investors and mentors involved in early-stage investment. Mission Our mission is to promote best practice in order to reduce risk in early-stage investments for the benefit of entrepreneurs, investors and the community. Team Our members are drawn from private groups, including investors and mentors who are interested in supporting and/or financing early-stage ventures. Our members have in common a strong desire, willingness, and capability to support ventures. We invest in areas where we believe our group can be a true value-added investor. Within our group is an environment where self help and camaraderie predominate, and where members can develop confidence in their early-stage investment skills. Focus PCA typically invests in companies with pre-money valuations in the range of $5M - $50M, but we occasionally consider opportunities that are outside this range. We welcome and encourage all applicants which meet our criteria to apply.